Ticker Scorecard - EXEL Basics Company: Exelixis, Inc. Common Stock IPO Date: May 1, 2000 Sector: Healthcare Industry: Biotech Market Cap: $9.66B Activated in VL: True Average Daily Range Avg Daily Range: $0.24 | 2.21% Avg Daily Range (30 D): $0.50 | 1.43% Avg Daily Range (90 D): $0.44 | 1.41% Institutional Daily Volume Avg Daily Volume: 2.05M Avg Daily Volume (30 D): 1.66M Avg Daily Volume (90 D): 1.69M Trade Size Avg Trade Size (Sh.): 168 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 11,020 Avg Inst. Trade: $2.71M Avg Inst. Trade (30 D): $6.84M Avg Inst. Trade (90 D): $4.9M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.96M Avg Closing Trade (30 D): $14.98M Avg Closing Trade (90 D): $12.69M Avg Closing Volume: 317.52K     News Dec 7, 2024 @ 1:45 PM 2 Biotech Stocks to Buy Hand Over Fist in December... Source: Prosper Junior Bakiny Nov 25, 2024 @ 6:00 PM Neuroendocrine Tumors Market to Showcase Rapid Gro... Source: Delveinsight Nov 3, 2024 @ 11:41 AM 3 Magnificent Stocks Under $100 to Buy in November... Source: The Motley Fool Nov 3, 2024 @ 8:30 AM Reddit, Roblox And Garmin Are Among Top 10 Large C... Source: Lekha Gupta Oct 23, 2024 @ 1:53 PM 1 No-Brainer Stock to Buy With $40 Source: Prosper Junior Bakiny Financials   TTM Q3 2025 Q2 2025 Basic EPS $1.58 $.41 $.78 Diluted EPS $1.56 $.4 $.77 Revenue $ 2.08B $ 539.54M $ 637.18M Gross Profit $ 2B $ 522.21M $ 619.51M Net Income / Loss $ 466.92M $ 117.97M $ 226.12M Operating Income / Loss $ 523.2M $ 136.08M $ 275.87M Cost of Revenue $ 78M $ 17.33M $ 17.67M Net Cash Flow $ -138.51M $ 59.89M $ PE Ratio 23.31